Efficacy and Safety of Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over 2 RSV Seasons
#3PRI RANKED
Most Cited Paper
in Animal Virus Infections Studies
18 Months Post-Publication
Class of 2026
“Efficacy and Safety of Respiratory Syncytial Virus (RSV) Prefusion F Protein Vaccine (RSVPreF3 OA) in Older Adults Over 2 RSV Seasons”
A research intelligence initiative by Pepkio
pri.pepkio.com
Topics
RSVPreF3 OA · RSV vaccine · adjuvanted vaccine · older adults ≥60 years · RSV-associated lower respiratory tract disease · severe RSV-LRTD · vaccine efficacy over 2 RSV seasons · revaccination regimen · single-dose vaccine durability · phase 3 blinded trial · Reactogenicity · RSV season · RSV prefusion F protein
Share
Cite this ranking
Pepkio Research Index (PRI). Topics and Trends in Most Cited Animal Virus Infections Studies Papers, Class of 2026. https://pri.pepkio.com/top-papers/animal-virus-infections-studies/2026. Accessed 2026-10-24. Methodology Zheng Su, Tinsley Li, Thematic Shifts in Early-High-Impact Cancer Genomics and Diagnostics Research: A Bibliometric and Semantic Analysis. bioRxiv 2026.07.04.736459; doi: https://doi.org/10.64898/2026.07.04.736459